Projects per year
Organisation profile
Organisation profile
The Translational and Clinical Immunology group aims to discover novel molecular and cellular intervention candidates and identify diagnostic and prognostic biomarkers for non-communicable complex diseases and infectious diseases, by integrating both pre-clinical animal models and human samples from cohorts and clinical trials. The overall research topics of the group are divided into the following specific themes:
1. Identify novel mechanisms leading to immune tolerance through allergen-specific immunotherapies used for treating various allergic diseases (led by Prof. Markus Ollert).
2. Investigate the potential links between acute viral infection, host immune dysregulations and the subsequent development of autoimmune, allergic and neurological disorders (led by Prof. Markus Ollert).
3. Identify the molecular mechanisms underlying the immune ageing process and their implementation in ageing-associated diseases (led by Dr. Feng Hefeng).
4. Develop and apply cutting-edge deep immunophenotyping strategies to enhance the understanding of immune dysregulations in various complex and infectious diseases (led by Dr. Feng Hefeng).
Fingerprint
Collaborations and top research areas from the last five years
Profiles
-
Immediate-PD: Immune-mediated T-cell toxicity for early diagnosis and precision medicine in Parkinson’s Disease
Hefeng, F. Q. (PI) & Krüger, R. (PI)
Fondation du Pélican de Mie et Pierre Hippert-Faber, Fondation de Luxembourg
1/01/26 → 31/12/28
Project: Research
-
ImmunoGal: The α-Gal syndrome – Investigating immune reactions to tick bites leading to inflammation and allergic sensitization
Hilger, C. (PI), Kuehn, A. (Partner), Hübschen, J. (Partner), Hefeng, F. Q. (Partner), Petry, J. (Partner) & Swiontek, K. (Partner)
FNR - Fonds National de la Recherche
1/04/25 → 30/06/28
Project: Research
-
ClimAir: Climate change and air contamination: Artificial Intelligence applied on the correlation between air pollutants and non-communicable respiratory diseases in Europe.
Ollert, M. (PI) & Bazon, M. (Partner)
1/01/25 → 31/12/28
Project: Research
-
Converging Pathomechanisms Link SARS-CoV-2 Infection With Major Neurodegenerative Diseases
Hefeng, F. Q., Marti-Sarrias, A., Guvenilir, H. A., Vieira de Sa, R., Sridhar, A., Haferkamp, U., El Kach-Marso, F., Bauermeister, S., Hudak, A., Roubanis, A., Ohnmacht, J., Sethumadhava, P., Ollert, M., Hofmann-Apitius, M., Navarro, A., Kodamullil, A. T., Pless, O., Letoha, T., Acosta, S. & Krüger, R., 27 Feb 2026, 67 p.Research output: Working paper › Preprint
-
Stepwise single-cell-resolved deep immunophenotyping pipeline to characterize immune heterogeneity and functionality in health and disease
Roubanis, A., Mei, Z., Hedin, F., Ammerlaan, W., Ollert, M., Cosma, A. & Hefeng, F. Q., 29 Jan 2026, 26 p.Research output: Working paper › Preprint
-
Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study
Sousa-Pinto, B., Louis, R., Anto, J. M., Amaral, R., Sá-Sousa, A., Czarlewski, W., Brussino, L., Canonica, G. W., Chaves Loureiro, C., Cruz, A. A., Gemicioglu, B., Haahtela, T., Kupczyk, M., Kvedariene, V., Larenas-Linnemann, D. E., Okamoto, Y., Ollert, M., Pfaar, O., Pham-Thi, N. & Puggioni, F. & 49 others, , 31 Dec 2025, In: Pulmonology. 31, 1, 2416869.Research output: Contribution to journal › Article › Research › peer-review
Open Access15 Citations (Scopus)